COSTAR GROUP INC (CSGP)

US22160N1090 - Common Stock

71.34  +0.98 (+1.39%)

After market: 71.34 0 (0%)

Fundamental Rating

5

CSGP gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 65 industry peers in the Real Estate Management & Development industry. CSGP has an average financial health and profitability rating. CSGP is quite expensive at the moment. It does show a decent growth rate.



6

1. Profitability

1.1 Basic Checks

CSGP had positive earnings in the past year.
In the past year CSGP had a positive cash flow from operations.
In the past 5 years CSGP has always been profitable.
CSGP had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 1.92%, CSGP is in the better half of the industry, outperforming 75.41% of the companies in the same industry.
CSGP has a better Return On Equity (2.34%) than 68.85% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.30%, CSGP is in line with its industry, outperforming 57.38% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CSGP is in line with the industry average of 4.87%.
Industry RankSector Rank
ROA 1.92%
ROE 2.34%
ROIC 0.3%
ROA(3y)4.21%
ROA(5y)4.82%
ROE(3y)5.2%
ROE(5y)5.82%
ROIC(3y)3.82%
ROIC(5y)4.45%

1.3 Margins

The Profit Margin of CSGP (6.58%) is better than 81.97% of its industry peers.
CSGP's Profit Margin has declined in the last couple of years.
CSGP's Operating Margin of 1.28% is fine compared to the rest of the industry. CSGP outperforms 60.66% of its industry peers.
CSGP's Operating Margin has declined in the last couple of years.
CSGP has a Gross Margin of 79.23%. This is amongst the best in the industry. CSGP outperforms 91.80% of its industry peers.
In the last couple of years the Gross Margin of CSGP has remained more or less at the same level.
Industry RankSector Rank
OM 1.28%
PM (TTM) 6.58%
GM 79.23%
OM growth 3Y-12.95%
OM growth 5Y-12.91%
PM growth 3Y3.69%
PM growth 5Y-5.26%
GM growth 3Y-0.58%
GM growth 5Y0.67%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CSGP is destroying value.
Compared to 1 year ago, CSGP has more shares outstanding
The number of shares outstanding for CSGP has been increased compared to 5 years ago.
The debt/assets ratio for CSGP has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 11.92 indicates that CSGP is not in any danger for bankruptcy at the moment.
CSGP has a Altman-Z score of 11.92. This is amongst the best in the industry. CSGP outperforms 90.16% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that CSGP is not too dependend on debt financing.
CSGP's Debt to Equity ratio of 0.13 is fine compared to the rest of the industry. CSGP outperforms 75.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 11.92
ROIC/WACC0.03
WACC9.08%

2.3 Liquidity

A Current Ratio of 9.63 indicates that CSGP has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 9.63, CSGP belongs to the top of the industry, outperforming 91.80% of the companies in the same industry.
A Quick Ratio of 9.63 indicates that CSGP has no problem at all paying its short term obligations.
CSGP's Quick ratio of 9.63 is amongst the best of the industry. CSGP outperforms 93.44% of its industry peers.
Industry RankSector Rank
Current Ratio 9.63
Quick Ratio 9.63

6

3. Growth

3.1 Past

The earnings per share for CSGP have decreased strongly by -37.50% in the last year.
The Earnings Per Share has been growing by 8.24% on average over the past years. This is quite good.
The Revenue has grown by 11.66% in the past year. This is quite good.
The Revenue has been growing by 15.55% on average over the past years. This is quite good.
EPS 1Y (TTM)-37.5%
EPS 3Y7.54%
EPS 5Y8.24%
EPS Q2Q%-26.67%
Revenue 1Y (TTM)11.66%
Revenue growth 3Y13.96%
Revenue growth 5Y15.55%
Sales Q2Q%10.87%

3.2 Future

CSGP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.35% yearly.
The Revenue is expected to grow by 14.20% on average over the next years. This is quite good.
EPS Next Y-43.25%
EPS Next 2Y-3.12%
EPS Next 3Y14.17%
EPS Next 5Y24.35%
Revenue Next Year11.53%
Revenue Next 2Y12.19%
Revenue Next 3Y13.29%
Revenue Next 5Y14.2%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 89.17, which means the current valuation is very expensive for CSGP.
Compared to the rest of the industry, the Price/Earnings ratio of CSGP is on the same level as its industry peers.
CSGP's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.34.
CSGP is valuated quite expensively with a Price/Forward Earnings ratio of 61.79.
CSGP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CSGP is cheaper than 68.85% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.61, CSGP is valued quite expensively.
Industry RankSector Rank
PE 89.18
Fwd PE 61.79

4.2 Price Multiples

CSGP's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 148.54

4.3 Compensation for Growth

The decent profitability rating of CSGP may justify a higher PE ratio.
A more expensive valuation may be justified as CSGP's earnings are expected to grow with 14.17% in the coming years.
PEG (NY)N/A
PEG (5Y)10.83
EPS Next 2Y-3.12%
EPS Next 3Y14.17%

0

5. Dividend

5.1 Amount

No dividends for CSGP!.
Industry RankSector Rank
Dividend Yield N/A

COSTAR GROUP INC

NASDAQ:CSGP (1/8/2025, 8:00:00 PM)

After market: 71.34 0 (0%)

71.34

+0.98 (+1.39%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)10-22 2024-10-22/amc
Earnings (Next)02-18 2025-02-18/amc
Inst Owners100.57%
Inst Owner Change0%
Ins Owners1.1%
Ins Owner Change-2.48%
Market Cap29.25B
Analysts82
Price Target92.91 (30.24%)
Short Float %2.9%
Short Ratio3.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.37%
Min EPS beat(2)32.76%
Max EPS beat(2)59.97%
EPS beat(4)4
Avg EPS beat(4)35.93%
Min EPS beat(4)1.92%
Max EPS beat(4)59.97%
EPS beat(8)7
Avg EPS beat(8)20.15%
EPS beat(12)11
Avg EPS beat(12)20.34%
EPS beat(16)15
Avg EPS beat(16)18.2%
Revenue beat(2)0
Avg Revenue beat(2)-2.17%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)-1.88%
Revenue beat(4)0
Avg Revenue beat(4)-1.6%
Min Revenue beat(4)-2.45%
Max Revenue beat(4)-1.01%
Revenue beat(8)0
Avg Revenue beat(8)-1.78%
Revenue beat(12)0
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.35%
PT rev (1m)0.18%
PT rev (3m)-3.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-15.42%
EPS NY rev (1m)-0.59%
EPS NY rev (3m)4.03%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.69%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)-0.46%
Valuation
Industry RankSector Rank
PE 89.18
Fwd PE 61.79
P/S 10.97
P/FCF N/A
P/OCF 65.5
P/B 3.9
P/tB 6.13
EV/EBITDA 148.54
EPS(TTM)0.8
EY1.12%
EPS(NY)1.15
Fwd EY1.62%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)1.09
OCFY1.53%
SpS6.51
BVpS18.27
TBVpS11.63
PEG (NY)N/A
PEG (5Y)10.83
Profitability
Industry RankSector Rank
ROA 1.92%
ROE 2.34%
ROCE 0.4%
ROIC 0.3%
ROICexc 0.7%
ROICexgc 2.74%
OM 1.28%
PM (TTM) 6.58%
GM 79.23%
FCFM N/A
ROA(3y)4.21%
ROA(5y)4.82%
ROE(3y)5.2%
ROE(5y)5.82%
ROIC(3y)3.82%
ROIC(5y)4.45%
ROICexc(3y)9.39%
ROICexc(5y)9.3%
ROICexgc(3y)72.51%
ROICexgc(5y)89.84%
ROCE(3y)5.07%
ROCE(5y)5.91%
ROICexcg growth 3Y-33.4%
ROICexcg growth 5Y-21.53%
ROICexc growth 3Y-5.27%
ROICexc growth 5Y-8.15%
OM growth 3Y-12.95%
OM growth 5Y-12.91%
PM growth 3Y3.69%
PM growth 5Y-5.26%
GM growth 3Y-0.58%
GM growth 5Y0.67%
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA 5.89
Cap/Depr 459.21%
Cap/Sales 23.47%
Interest Coverage 1.12
Cash Conversion 261.97%
Profit Quality N/A
Current Ratio 9.63
Quick Ratio 9.63
Altman-Z 11.92
F-Score5
WACC9.08%
ROIC/WACC0.03
Cap/Depr(3y)112.06%
Cap/Depr(5y)86.88%
Cap/Sales(3y)6.61%
Cap/Sales(5y)5.21%
Profit Quality(3y)97.54%
Profit Quality(5y)123.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-37.5%
EPS 3Y7.54%
EPS 5Y8.24%
EPS Q2Q%-26.67%
EPS Next Y-43.25%
EPS Next 2Y-3.12%
EPS Next 3Y14.17%
EPS Next 5Y24.35%
Revenue 1Y (TTM)11.66%
Revenue growth 3Y13.96%
Revenue growth 5Y15.55%
Sales Q2Q%10.87%
Revenue Next Year11.53%
Revenue Next 2Y12.19%
Revenue Next 3Y13.29%
Revenue Next 5Y14.2%
EBIT growth 1Y-89.96%
EBIT growth 3Y-0.8%
EBIT growth 5Y0.63%
EBIT Next Year-39.4%
EBIT Next 3Y34.81%
EBIT Next 5Y34.44%
FCF growth 1Y-155.18%
FCF growth 3Y-7.48%
FCF growth 5Y2.54%
OCF growth 1Y0.54%
OCF growth 3Y0.23%
OCF growth 5Y7.85%